Solid Biosciences Price To Book vs. Return On Asset

SLDB Stock  USD 7.56  0.01  0.13%   
Based on Solid Biosciences' profitability indicators, Solid Biosciences LLC may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in June. Profitability indicators assess Solid Biosciences' ability to earn profits and add value for shareholders. At present, Solid Biosciences' Price To Sales Ratio is projected to drop slightly based on the last few years of reporting. The current year's Price Sales Ratio is expected to grow to 10.66, whereas Days Sales Outstanding is forecasted to decline to 2.36. At present, Solid Biosciences' Accumulated Other Comprehensive Income is projected to decrease significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 7.4 M, whereas Operating Income is forecasted to decline to (109.5 M).
For Solid Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Solid Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Solid Biosciences LLC utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Solid Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Solid Biosciences LLC over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Is Solid Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Solid Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.82)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.31)
Return On Equity
(0.57)
The market value of Solid Biosciences LLC is measured differently than its book value, which is the value of Solid that is recorded on the company's balance sheet. Investors also form their own opinion of Solid Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Solid Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Solid Biosciences' market value can be influenced by many factors that don't directly affect Solid Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Solid Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Solid Biosciences LLC Return On Asset vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Solid Biosciences's current stock value. Our valuation model uses many indicators to compare Solid Biosciences value to that of its competitors to determine the firm's financial worth.
Solid Biosciences LLC is currently regarded as top stock in price to book category among related companies. It is currently regarded as top stock in return on asset category among related companies . As of May 30, 2024, Return On Assets is expected to decline to -0.61. Comparative valuation analysis is a catch-all model that can be used if you cannot value Solid Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Solid Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Solid Biosciences' earnings, one of the primary drivers of an investment's value.

Solid Return On Asset vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Solid Biosciences

P/B

 = 

MV Per Share

BV Per Share

 = 
3.10 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Solid Biosciences

Return On Asset

 = 

Net Income

Total Assets

 = 
-0.31
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Solid Return On Asset Comparison

Solid Biosciences is currently under evaluation in return on asset category among related companies.

Solid Biosciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Solid Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Solid Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Solid Biosciences' change in net profit over the period of time. It can combine multiple indicators of Solid Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income15 K15.8 K
Interest IncomeM7.4 M
Operating Income-104.3 M-109.5 M
Net Loss-90.8 M-95.4 M
Income Before Tax-96 M-100.8 M
Total Other Income Expense Net8.3 M4.2 M
Net Loss-77.4 M-81.3 M
Net Loss-96 M-100.8 M
Income Tax Expense-18.4 M-17.5 M
Net Interest IncomeM7.4 M
Non Operating Income Net Other23.5 M24.7 M
Change To Netincome8.7 M7.7 M
Net Loss(4.83)(5.07)
Income Quality 0.98  0.70 
Net Income Per E B T 0.88  1.03 

Solid Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Solid Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Solid Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Solid Biosciences' important profitability drivers and their relationship over time.

Use Solid Biosciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Solid Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will appreciate offsetting losses from the drop in the long position's value.

Solid Biosciences Pair Trading

Solid Biosciences LLC Pair Trading Analysis

The ability to find closely correlated positions to Solid Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Solid Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Solid Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Solid Biosciences LLC to buy it.
The correlation of Solid Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Solid Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Solid Biosciences LLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Solid Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Solid Biosciences position

In addition to having Solid Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Macroaxis Picks Thematic Idea Now

Macroaxis Picks
Macroaxis Picks Theme
Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Solid Biosciences LLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Solid Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Solid Biosciences Llc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Solid Biosciences Llc Stock:
Check out World Market Map.
Note that the Solid Biosciences LLC information on this page should be used as a complementary analysis to other Solid Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Solid Stock analysis

When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
CEOs Directory
Screen CEOs from public companies around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
To fully project Solid Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Solid Biosciences LLC at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Solid Biosciences' income statement, its balance sheet, and the statement of cash flows.
Potential Solid Biosciences investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Solid Biosciences investors may work on each financial statement separately, they are all related. The changes in Solid Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Solid Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.